New indications, dosage regimes and combinations

Innovative development of a previously known drug can make a significant contribution to treatment of a new indication and often unlocks the potential of a pharmaceutical product in the market. Likewise, a new dosage regimen can revolutionise patient care, convenience and compliance, and a new combination therapy can enable otherwise impossible efficacy.

Patents in these fields cover valuable research, and due to their clinical importance frequently attract third party oppositions and litigation. The Pharmaceuticals team handles some of the most valuable patents in Europe, working with clients and experts to develop an understanding of the therapeutic area, which we combine with a deep awareness of pharmaceutical patent law to achieve the best results for our clients.